ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.
Abstract
African green monkeys (AGM) and other natural hosts for simian immunodeficiency virus
(SIV) do not develop an AIDS-like disease following SIV infection. To evaluate differences
in the role of SIV-specific adaptive immune responses between natural and nonnatural
hosts, we used SIV(agmVer90) to infect vervet AGM and pigtailed macaques (PTM). This
infection results in robust viral replication in both vervet AGM and pigtailed macaques
(PTM) but only induces AIDS in the latter species. We delayed the development of adaptive
immune responses through combined administration of anti-CD8 and anti-CD20 lymphocyte-depleting
antibodies during primary infection of PTM (n = 4) and AGM (n = 4), and compared these
animals to historical controls infected with the same virus. Lymphocyte depletion
resulted in a 1-log increase in primary viremia and a 4-log increase in post-acute
viremia in PTM. Three of the four PTM had to be euthanized within 6 weeks of inoculation
due to massive CMV reactivation and disease. In contrast, all four lymphocyte-depleted
AGM remained healthy. The lymphocyte-depleted AGM showed only a trend toward a prolongation
in peak viremia but the groups were indistinguishable during chronic infection. These
data show that adaptive immune responses are critical for controlling disease progression
in pathogenic SIV infection in PTM. However, the maintenance of a disease-free course
of SIV infection in AGM likely depends on a number of mechanisms including non-adaptive
immune mechanisms.
Type
Journal articleSubject
Adaptive ImmunityAnimals
Antigens, CD20
B-Lymphocyte Subsets
Blotting, Western
CD8-Positive T-Lymphocytes
Cercopithecus aethiops
Immunohistochemistry
Immunophenotyping
In Situ Hybridization
Lymphocyte Depletion
Macaca nemestrina
Reverse Transcriptase Polymerase Chain Reaction
Simian Acquired Immunodeficiency Syndrome
Simian Immunodeficiency Virus
Viremia
Permalink
https://hdl.handle.net/10161/4591Published Version (Please cite this version)
10.1371/journal.ppat.1000691Publication Info
Schmitz, Jörn E; Zahn, Roland C; Brown, Charles R; Rett, Melisa D; Li, Ming; Tang,
Haili; ... Hirsch, Vanessa M (2009). Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected
pigtailed macaques but not vervet African green monkeys. PLoS Pathog, 5(12). pp. e1000691. 10.1371/journal.ppat.1000691. Retrieved from https://hdl.handle.net/10161/4591.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
David Charles Montefiori
Professor in Surgery
Dr. Montefiori is Professor and Director of the Laboratory for HIV and COVID-19 Vaccine
Research & Development in the Department of Surgery, Division of Surgical Sciences
at Duke University Medical Center. His major research interests are viral immunology
and HIV and COVID-19 vaccine development, with a special emphasis on neutralizing
antibodies. Multiple aspects of HIV-1 neutralizing antibodies are studied in his laboratory,
including mechanisms of neutralization and escape,

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info